Product Code: ETC13346191 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
Global Pneumococcal Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Pneumococcal Vaccines Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Global Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Global Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Global Pneumococcal Vaccines Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.8 Global Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Pneumococcal Vaccines Market Trends |
6 Global Pneumococcal Vaccines Market, 2021 - 2031 |
6.1 Global Pneumococcal Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Pneumococcal Vaccines Market, Revenues & Volume, By Conjugate, 2021 - 2031 |
6.1.3 Global Pneumococcal Vaccines Market, Revenues & Volume, By Polysaccharide, 2021 - 2031 |
6.1.4 Global Pneumococcal Vaccines Market, Revenues & Volume, By Combination, 2021 - 2031 |
6.1.5 Global Pneumococcal Vaccines Market, Revenues & Volume, By Live Attenuated, 2021 - 2031 |
6.1.6 Global Pneumococcal Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Pneumococcal Vaccines Market, Revenues & Volume, By Vaccine Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Pneumococcal Vaccines Market, Revenues & Volume, By Protein-based, 2021 - 2031 |
6.2.3 Global Pneumococcal Vaccines Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.2.4 Global Pneumococcal Vaccines Market, Revenues & Volume, By Inactivated, 2021 - 2031 |
6.2.5 Global Pneumococcal Vaccines Market, Revenues & Volume, By mRNA-based, 2021 - 2031 |
6.2.6 Global Pneumococcal Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Pneumococcal Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Pneumococcal Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Pneumococcal Vaccines Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.4 Global Pneumococcal Vaccines Market, Revenues & Volume, By Government, 2021 - 2031 |
6.3.5 Global Pneumococcal Vaccines Market, Revenues & Volume, By NGOs, 2021 - 2031 |
6.3.6 Global Pneumococcal Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Pneumococcal Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Pneumococcal Vaccines Market, Revenues & Volume, By Immunization, 2021 - 2031 |
6.4.3 Global Pneumococcal Vaccines Market, Revenues & Volume, By Disease Prevention, 2021 - 2031 |
6.4.4 Global Pneumococcal Vaccines Market, Revenues & Volume, By Pediatric Vaccination, 2021 - 2031 |
6.4.5 Global Pneumococcal Vaccines Market, Revenues & Volume, By Elderly Care, 2021 - 2031 |
6.4.6 Global Pneumococcal Vaccines Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Pneumococcal Vaccines Market, Overview & Analysis |
7.1 North America Pneumococcal Vaccines Market Revenues & Volume, 2021 - 2031 |
7.2 North America Pneumococcal Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Pneumococcal Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Pneumococcal Vaccines Market, Revenues & Volume, By Vaccine Technology, 2021 - 2031 |
7.5 North America Pneumococcal Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Pneumococcal Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Pneumococcal Vaccines Market, Overview & Analysis |
8.1 Latin America (LATAM) Pneumococcal Vaccines Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Pneumococcal Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Pneumococcal Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Pneumococcal Vaccines Market, Revenues & Volume, By Vaccine Technology, 2021 - 2031 |
8.5 Latin America (LATAM) Pneumococcal Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Pneumococcal Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Pneumococcal Vaccines Market, Overview & Analysis |
9.1 Asia Pneumococcal Vaccines Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Pneumococcal Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Pneumococcal Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Pneumococcal Vaccines Market, Revenues & Volume, By Vaccine Technology, 2021 - 2031 |
9.5 Asia Pneumococcal Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Pneumococcal Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Pneumococcal Vaccines Market, Overview & Analysis |
10.1 Africa Pneumococcal Vaccines Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Pneumococcal Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Pneumococcal Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Pneumococcal Vaccines Market, Revenues & Volume, By Vaccine Technology, 2021 - 2031 |
10.5 Africa Pneumococcal Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Pneumococcal Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Pneumococcal Vaccines Market, Overview & Analysis |
11.1 Europe Pneumococcal Vaccines Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Pneumococcal Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Pneumococcal Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Pneumococcal Vaccines Market, Revenues & Volume, By Vaccine Technology, 2021 - 2031 |
11.5 Europe Pneumococcal Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Pneumococcal Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Pneumococcal Vaccines Market, Overview & Analysis |
12.1 Middle East Pneumococcal Vaccines Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Pneumococcal Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Pneumococcal Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Pneumococcal Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Pneumococcal Vaccines Market, Revenues & Volume, By Vaccine Technology, 2021 - 2031 |
12.5 Middle East Pneumococcal Vaccines Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Pneumococcal Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Pneumococcal Vaccines Market Key Performance Indicators |
14 Global Pneumococcal Vaccines Market - Export/Import By Countries Assessment |
15 Global Pneumococcal Vaccines Market - Opportunity Assessment |
15.1 Global Pneumococcal Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
15.4 Global Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Pneumococcal Vaccines Market - Competitive Landscape |
16.1 Global Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
16.2 Global Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |